In This Issue
Thirty years after the first medical reports about AIDS, cure research is once again heating up, thanks to the dedication of advocates and researchers and the courage of clinical trial volunteers. Below you will find an in-depth article on current prospects for curing HIV. Other articles in this issue offer information on equipping yourself to live long and well with the virus.
A cure has always been the elusive “holy grail” of HIV/AIDS research. Promising new cure studies have researchers and advocates worldwide asking: Is lifelong treatment the best we can do? Read more...
People with HIV are susceptible to bone loss and fractures—particularly with advancing age. Research is underway to better understand, prevent, and treat bone problems in HIV positive people. Read more...
More people living with HIV are hoping to become parents, as better treatments extend life spans and improve health. Many options—including assisted reproduction and adoption—are available to positive would-be parents. Read more...
The 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011), which took place February 27–March 2 in Boston, is one of the major annual scientific meetings covering HIV/AIDS and its management. Reports of highlights from the conference are included below, along with recent news from medical journals and other sources. Read more...
Dolutegravir (also known as GSK52), a second-generation integrase inhibitor, is currently in development for first-line antiretroviral therapy and for treatment-experienced people. Read more...
Since launching in 2008, the U.S. Positive Women’s Network (PWN), a project of Women Organized to Respond to Life-threatening Disease (WORLD) in Oakland, California, has worked to unite HIV positive women across the country and give advocates a cohesive voice. PWN coordinator Naina Khanna and communications coordinator Sonia Rastogi recently sat down with BETA to give an update on the network’s current and upcoming activities.Read more...
A selection of currently enrolling clinical trials of treatments for HIV and AIDS-related conditions. Read more...
These articles are published as PDFs, for which you need some version of the Adobe Reader. You can click on the image to the right to download it if you don't have it.
If your browser won't let you open those links, please let us know.